These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6492939

  • 1. [Preparation of delayed-action staphylococcal vaccine. II. Effect of the vaccine on the course of generalized infection in mice].
    Giedrys-Galant S, Hałasa J, Podkowińska I.
    Med Dosw Mikrobiol; 1984; 36(2):87-91. PubMed ID: 6492939
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C.
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract] [Full Text] [Related]

  • 4. [Immunogenicity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. II. Staphylococcal vaccine].
    Wysokińska T, Albrycht H.
    Med Dosw Mikrobiol; 1973 Sep; 25(3):205-11. PubMed ID: 4760223
    [No Abstract] [Full Text] [Related]

  • 5. Vaccine could help fight deadly hospital-acquired infections.
    Levenson D.
    Rep Med Guidel Outcomes Res; 2002 Mar 22; 13(6):9-10, 12. PubMed ID: 12449105
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Immunogenecity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. I. Staphylococcal toxoid].
    Wysokìnska T, Albrycht H.
    Med Dosw Mikrobiol; 1973 Mar 22; 25(3):193-204. PubMed ID: 4760222
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR, Black S.
    Expert Rev Vaccines; 2005 Oct 22; 4(5):669-76. PubMed ID: 16221068
    [Abstract] [Full Text] [Related]

  • 11. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
    Nilsson IM, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A.
    J Infect Dis; 1999 Oct 22; 180(4):1370-3. PubMed ID: 10479175
    [Abstract] [Full Text] [Related]

  • 12. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR, Black S.
    Pediatr Infect Dis J; 2006 Feb 22; 25(2):167-8. PubMed ID: 16462297
    [No Abstract] [Full Text] [Related]

  • 13. [Experimental study of staphylococcal infection with special reference to the preventive effect on "infection death" on mice pretreated with live or chrome-killed vaccine of various staphylococcal strains].
    Abe M.
    Nihon Saikingaku Zasshi; 1966 Mar 22; (3):125-32. PubMed ID: 6005851
    [No Abstract] [Full Text] [Related]

  • 14. [Controversy in asthma. II. A new vaccine prepared with the Cowan I strain of Staphylococcus aureus].
    del Real Sánchez JH.
    Rev Alerg Mex (1987); 1987 Mar 22; 34(4):99-105. PubMed ID: 3324814
    [No Abstract] [Full Text] [Related]

  • 15. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis.
    Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA.
    Vet Immunol Immunopathol; 2006 Jan 15; 109(1-2):85-97. PubMed ID: 16165220
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of antibiotic therapy and vaccine therapy on the phagocytic reaction in mice infected with Staphylococcus].
    Balakliets NI, Tsyganenko AIa.
    Antibiotiki; 1983 Mar 15; 28(3):204-9. PubMed ID: 6859821
    [Abstract] [Full Text] [Related]

  • 19. [Staphylococcal antifagin in combined therapy of chronic purulent sinusitis].
    Magomedov KhR.
    Vestn Otorinolaringol; 2008 Mar 15; (5):54-6. PubMed ID: 19065705
    [No Abstract] [Full Text] [Related]

  • 20. Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design.
    Nanra JS, Timofeyeva Y, Buitrago SM, Sellman BR, Dilts DA, Fink P, Nunez L, Hagen M, Matsuka YV, Mininni T, Zhu D, Pavliak V, Green BA, Jansen KU, Anderson AS.
    Vaccine; 2009 May 26; 27(25-26):3276-80. PubMed ID: 19200819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.